Results 91 to 100 of about 932 (190)

Comparative effectiveness of myocardial cytoprotectors in chronic heart failure treatment

open access: yesРоссийский кардиологический журнал, 2007
The study is focused on comparative effectiveness of myocardial cytoprotectors in chronic heart failure (CHF) treatment. In total, 120 patients with Functional Class (FC) II-III CHF were divided into two groups.
G. G. Semenkova, L. V. Kokoreva
doaj  

Importance of the Pharmacological Synergismin Modern Concept of Anti-Ischemic Therapy [PDF]

open access: yes, 2020
Nowadays, the increase of therapy efficacy of ischemic conditions in cardiology and neurology is one of the top trends in clinical, pharmaceutical and pharmacological studies on a global scale.
I A Zupanets
core  

New views of mildronate use for the prevention and correction of impairment of adaptive processes

open access: yesRUDN Journal of Medicine, 2009
Protective and normalizing mildronate action on the level of non enzyme kation proteins in the neurophils and contents of kateholamins in erythrocytes were revealed on the experimental model of the emotional-pain stress.
L V Logunova
doaj  

COMPUTATIONAL ANALYSIS OF INTERACTIONS BETWEEN ANTI-EPILEPTIC DRUGS AND IMPORTANT PLACENTAL PROTEINS-A POSSIBLE ROUTE FOR NEURAL TUBE DEFECTS IN HUMANS [PDF]

open access: yes, 2016
Objective: The reason behind the occurrence of Neural Tube Defects (NTDs) in pregnant women treated with certain Anti-Epileptic Drugs (AEDs) such as Carbamazepine, Valproate, Lamotrigine, Phenobarbital, etc., is not yet known.
Agrawal, Arvind   +3 more
core   +1 more source

Mildronate (meldonium): First, do no harm

open access: yes, 2020
Meldonium (Mildronate) is used as a cardioprotective drug; however, it has not been officially approved anywhere outside the former Soviet Union (SU). The supposed action mechanism is based on the carnitine (Lcarnitine) lowering effect in muscular and cardiac tissues.
openaire   +1 more source

Study of the cardioprotective metabolic effects of mildronate [PDF]

open access: yes, 2020
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Disciplina de medicină internă-semiologie, Chișinău, Republica Moldova, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae ...
Chetruș, Olga
core  

MAIN THERAPEUTIC PRINCIPLES IN PREMENOPAUSAL WOMEN

open access: yesРоссийский кардиологический журнал, 2011
The review outlines the main mechanisms of protective estrogen effects on cardiovascular system and the role of estrogen deficiency in cardiovascular disease (CVD) development. The position of the International Menopause Society (2009) on CVD in women is
S. N. Tolstov   +5 more
doaj  

Cardioprotective effect of hydroxybenzoic acid ester containing neuroactive acid, compound F-26, in conditions of isoproterenol heart failure in rats

open access: yesResearch Results in Pharmacology
Introduction: Currently, chronic heart failure (CHF) is one of the leading problems of modern healthcare. Its most common manifestation is the deterioration of the inotropic reserves of the heart muscle, which over time leads to decompensation and damage
Valentin Kataev   +8 more
doaj   +1 more source

CYTOPROTECTOR MILDRONATE IN CORRECTING MYOCARDIAL DYSFUNCTION AMONG STABLE ANGINA PATIENTS AFTER CORONARY REVASCULARISATION

open access: yesРоссийский кардиологический журнал, 2009
In total, 149 patients, aged 41–75 years, with Functional Class (FC) II-III stable angina, who underwent coronary artery bypass graft surgery (CABG) or percutaneous coronary intervention (PCI), were examined.
I. G. Gordeev   +2 more
doaj  

Home - About - Disclaimer - Privacy